Education
About Us
Working with TipRanks
Follow Us
Apellis Pharmaceuticals (APLS)
:APLS
Apellis Pharmaceuticals (APLS) Ownership Overview
3.43% Insiders
21.41% Mutual Funds
38.59% Other Institutional Investors
14.97% ETFs
21.59% Public Companies and Individual Investors
The ownership structure of Apellis Pharmaceuticals (APLS) stock is a mix of institutional, retail, and individual investors. Approximately 74.97% of the company’s stock is owned by Institutional Investors, 3.43% is owned by Insiders, and 21.59% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 18, 2025 | xxxxxxxxxxxxx | $4542 | |
Mar 06, 2025 | xxxxxxxxxxxxx | $139782 | |
Feb 12, 2025 | xxxxxxxxxxxxx | $10356 | |
Jan 30, 2025 | xxxxxxxxxxxxx | $24384 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $615334 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $4786249 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,626,786 | Institution | 7.66% | 167,987,416 | |
| 9,127,732 | Institution | 7.26% | 159,278,923 | |
| 8,477,414 | Institution | 6.75% | 147,930,874 | |
| 2,689,328 | Institution | 2.14% | 46,928,774 | |
| 2,647,478 | Institution | 2.11% | 46,198,491 | |
| 2,210,140 | Institution | 1.76% | 38,566,943 | |
| 1,955,117 | Insider | 1.56% | 34,116,792 | |
| 1,147,716 | Insider | 0.91% | 20,027,644 | |
| 1,073,415 | Institution | 0.85% | 18,731,092 | |
| 1,029,036 | Institution | 0.82% | 17,956,678 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,127,732 | Institution | 7.26% | 159,278,923 | |
| 8,477,414 | Institution | 6.75% | 147,930,874 | |
| 1,073,415 | Institution | 0.85% | 18,731,092 | |
| 1,029,036 | Institution | 0.82% | 17,956,678 | |
| 986,546 | Institution | 0.78% | 17,215,228 | |
| 849,481 | Institution | 0.68% | 14,823,443 | |
| 534,859 | Institution | 0.43% | 9,333,290 | |
| 494,436 | Institution | 0.39% | 8,627,908 | |
| 467,487 | Institution | 0.37% | 8,157,648 | |
| 390,430 | Institution | 0.31% | 6,813,004 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,410,961 | Institution | 2.71% | 65,524,561 | |
| 2,691,834 | Institution | 2.14% | 85,896,423 | |
| 2,149,859 | Institution | 1.71% | 35,171,693 | |
| 1,649,750 | Institution | 1.31% | 31,691,698 | |
| 1,479,527 | Institution | 1.18% | 28,421,714 | |
| 646,905 | Institution | 0.51% | 11,288,492 | |
| 630,249 | Institution | 0.50% | 10,997,845 | |
| 516,036 | Institution | 0.41% | 7,685,202 | |
| 516,036 | Institution | 0.41% | 7,685,202 | |
| 516,036 | Institution | 0.41% | 7,685,202 |
FAQ
Who Owns Apellis Pharmaceuticals (APLS)?
According to the latest TipRanks data, approximately 38.59% of the company's stock is held by institutional investors, 3.43% is held by insiders, and 21.59% is held by retail investors.
What percentage of Apellis Pharmaceuticals (APLS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.59% of Apellis Pharmaceuticals (APLS) stock is held by institutional investors.
What percentage of Apellis Pharmaceuticals (APLS) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.59% of Apellis Pharmaceuticals (APLS) stock is held by retail investors.
Who owns the most shares of Apellis Pharmaceuticals (APLS)?
Vanguard owns the most shares of Apellis Pharmaceuticals (APLS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.